Phase II Study of Combination of Hyper-CVAD with Ponatinib in Frontline Therapy of Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph-positive ALL)

Publication date: September 2015 Source:Clinical Lymphoma Myeloma and Leukemia, Volume 15, Supplement 2 Author(s): Koji Sasaki, Susan O’Brien, Farhad Ravandi, Deborah Thomas, Haim G. Moore, Jorge Cortes, Naveen Pemmaraju, Musa Yilmaz, Tapan Kadia, Rebecca Garris, Guillermo Garcia-Manero, Vicky Jeanis, Gautam Borthakur, William Wierda, Alessandra Ferrajoli, Hagop Kantarjian, Elias Jabbour
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research